EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links


[ÀÏ¿ø³»½Ã°æ±³½Ç ¿ù¿äÁ¡½ÉÁý´ãȸ 2016-5-16. ½Åµ¿Çö ±³¼ö´Ô Ư°­ (alcoholic hepatitis)]

Previous | Next

½Åµ¿Çö ±³¼ö´ÔÀÇ ¸ÚÁø Ư°­ÀÌ ÀÖ¾ú½À´Ï´Ù. Á¦¸ñÀº alcoholic hepatitisÀÔ´Ï´Ù. Á¤È®È÷ Áø´ÜÇÏ¿© ÀûÀýÈ÷ steroid¸¦ ¾²ÀÚ´Â °ÍÀÌ ¿äÁö¶ó°í »ý°¢µË´Ï´Ù. ÀλóÀûÀÎ ½½¶óÀÌµå ¸î Àå °ñ¶óº¸¾Ò½À´Ï´Ù.

Patients must first be accurately diagnosed with AH, based on history, physical examination, and analyses of blood samples and, in some cases, biopsies collected via the transjugular route. Alcohol dependence should be determined and treated initiated at this point. Patients should then be assessed for complications such as infections, upper gastrointestinal bleeding, and renal failure. Patients¡¯ nutritional needs should then be addressed; patients should be given 35 - 40 cal/kg/day orally or enterally, as well as 1.2 - 1.5 g protein/kg/day. The severity of AH should then be assessed. Patients with a MDF¡Ã32 and MELD>20 should receive prednisolone (40 mg/day) with or without NAC for 7 days, and then bilirubin should be measured. Patients with Lille scores below 0.45 should continue treatment for 28 days. Patients with Lille scores above 0.45 should stop treatment. There are no specific treatments for patients with DF<32 and MELD¡Â20.

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà